ArticleScientific reports2025
The association of nutritional and inflammatory status with cardiovascular and all-cause mortality risk among US patients with metabolic syndrome.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Long-Term Clinical Outcomes of PCI Versus Medical Therapy in NSTEMI Patients with Prior CABG.Medicina (Kaunas, Lithuania) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
To investigate the relationship between nutritional and inflammatory status and all-cause and cardiovascular mortality in the U.S. population with cardiometabolic syndrome (CMS) and to identify the optimal nutrition-inflammation index for assessing long-term prognosis. Health data from the 1999-2010 National Health and Nutrition Examination Survey (NHANES) were used. Kaplan-Meier analysis explored associations between nutrition-inflammation indices and mortality in the CMS population. Significant indices were selected for ROC curve analysis, and the most effective index was analyzed using COX regression models. Restricted cubic splines (RCS) analyzed nonlinear associations, and a recursive algorithm determined inflection points. Subgroup and sensitivity analyses assessed the stability of the model. The study included data from 5,969 participants (2,900 males, 3,069 females), with 1,753 all-cause deaths and 607 cardiovascular deaths. Kaplan-Meier analysis indicated that good nutrition and low inflammation were linked to better long-term outcomes. The Advanced Lung Cancer Inflammation Index (ALI) was the most effective assessing index. COX regression showed a negative association between ALI and both mortality types. RCS analysis revealed a U-shaped relationship for all-cause mortality and an L-shaped curve for cardiovascular mortality, with an inflection point at 106.24. Subgroup analysis and sensitivity analysis confirmed the robustness of ALI in assessing the mortality risk in the CMS population. ALI is an ideal indicator for evaluating the relationship between nutritional and inflammatory status and both all-cause and cardiovascular mortality in the CMS population. Maintaining an appropriate ALI level can help reduce the risk of all-cause and cardiovascular mortality in CMS patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.